{"blog": [], "keywords": [{"value": "Hemophilia", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Novo Nordisk A/S", "name": "organizations", "rank": "11", "is_major": "N"}, {"value": "Baxalta Inc.", "name": "organizations", "rank": "12", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Conflicts of Interest", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Blood", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Ethics and Official Misconduct", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Hemophilia of North Carolina", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "National Hemophilia Foundation", "name": "organizations", "rank": "7", "is_major": "N"}, {"value": "MedfusionRx LLC", "name": "organizations", "rank": "8", "is_major": "N"}, {"value": "Bayer AG", "name": "organizations", "rank": "9", "is_major": "N"}, {"value": "Pfizer Inc", "name": "organizations", "rank": "10", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/01/14/business/hemophilia-patient-or-drug-seller-dual-role-creates-ethical-quandary.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "legacy": {"wide": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "xlargeheight": "398", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 398}, {"url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "1254", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "pub_date": "2016-01-14T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "The Patient&#8217;s Sales Pitch ", "main": "Hemophilia Patient or Drug Seller? Dual Role Creates Ethical Quandary"}, "print_page": "1", "snippet": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "_id": "569694b938f0d865e6c34836", "slideshow_credits": null, "abstract": "Increasing number of hemophilia drug makers and specialty pharmacies are employing patients and their relatives to gain sales advantage and increase revenue; ethical issues are raised. "}